Weight Loss Management

Elevated Weight Management, Guided by Science.


Regenova offers provider‑guided GLP‑1 and non‑GLP‑1 programs with personalized protocols designed to support consistent habits and help you make meaningful progress. Each plan is tailored to your needs, focusing on responsible treatment options, structured routines, and clear guidance to help you maximize results safely.

Featured Products

Retatrutide
$425.00

Retatrutide is an investigational next-generation peptide therapy currently being studied for advanced metabolic and weight management support. Retatrutide is unique because it targets three receptor pathways simultaneously:

  • GLP-1

  • GIP

  • Glucagon receptors

This triple-agonist mechanism has generated interest for its potential effects on energy balance, appetite regulation, and metabolic function.

Retatrutide remains investigational and has not received FDA approval for general clinical use.

Mechanism of Action

Retatrutide is being studied for its ability to support:

  • Appetite regulation

  • Satiety enhancement

  • Energy expenditure

  • Metabolic efficiency

  • Glucose regulation

  • Body composition management

Its glucagon receptor activity may additionally support increased energy utilization and metabolic activity.

Potential Benefits Under Investigation

Current research is evaluating potential roles in:

  • Advanced weight management

  • Metabolic health optimization

  • Cardiometabolic wellness

  • Energy balance

  • Appetite reduction

  • Body composition support

Research Status

Retatrutide is currently under clinical investigation and continues to be evaluated in ongoing metabolic health and obesity-related studies.

Investigational therapies should only be utilized in accordance with applicable medical and regulatory guidance.

Tirzepatide
$300.00

Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support advanced metabolic and weight management goals. Unlike traditional GLP-1 therapies alone, tirzepatide targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways to provide broader metabolic support.

Brand medications associated with tirzepatide include:

  • Mounjaro®

  • Zepbound®

Mechanism of Action

Tirzepatide works through dual receptor activity that may support:

  • Appetite suppression

  • Satiety signaling

  • Blood sugar regulation

  • Insulin sensitivity

  • Reduced caloric intake

  • Metabolic efficiency

The combined GIP and GLP-1 receptor activity has generated significant interest in advanced metabolic wellness and body composition management.

Potential Benefits

Potential benefits associated with tirzepatide therapy may include:

  • Significant appetite reduction

  • Weight management support

  • Improved insulin sensitivity

  • Reduced food cravings

  • Metabolic optimization

  • Cardiometabolic wellness support

  • Body composition improvement

Areas of Clinical Interest

Tirzepatide is increasingly utilized within wellness programs focused on:

  • Weight management

  • Metabolic syndrome support

  • Blood sugar regulation

  • Lifestyle optimization

  • Long-term metabolic health

Administration

Tirzepatide is commonly administered as:

  • Once-weekly subcutaneous injection

Treatment protocols are individualized based on patient-specific wellness goals and provider guidance.

Semaglutide
$199.00

Semaglutide

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist designed to mimic naturally occurring incretin hormones involved in glucose regulation and appetite signaling. Semaglutide works by stimulating GLP-1 receptors that help regulate hunger, insulin secretion, gastric emptying, and blood sugar balance.

Semaglutide has become one of the most widely recognized peptide therapies for metabolic support and chronic weight management.

Brand medications associated with semaglutide include:

  • Ozempic®

  • Wegovy®

Mechanism of Action

Semaglutide may help support metabolic health through several pathways, including:

  • Delaying gastric emptying

  • Promoting satiety and fullness

  • Reducing appetite and food cravings

  • Supporting insulin release in response to meals

  • Reducing glucagon secretion

  • Supporting blood sugar balance

These combined effects may help support sustainable caloric reduction and long-term metabolic wellness.

Potential Benefits

Potential benefits associated with semaglutide therapy may include:

  • Weight management support

  • Reduced appetite and cravings

  • Improved portion control

  • Support for healthy blood sugar regulation

  • Metabolic wellness support

  • Cardiometabolic health support

  • Body composition improvement

Individual results may vary based on lifestyle, nutrition, activity level, and treatment adherence.

Areas of Clinical Use

Semaglutide has been utilized within programs focused on:

  • Chronic weight management

  • Metabolic health optimization

  • Type 2 diabetes management

  • Appetite regulation

  • Wellness and longevity support

Administration

Semaglutide is typically administered as:

  • Once-weekly subcutaneous injection

Dosing protocols are individualized and generally escalated gradually to support tolerability and patient response.

Important Safety and Information and Common Side Effects

Semaglutide is a GLP-1 receptor agonist designed to support appetite regulation, blood sugar balance, and weight management. By mimicking naturally occurring GLP-1 hormones, Semaglutide may help reduce hunger signals, improve satiety, and support sustainable metabolic health goals.

Semaglutide

Potential benefits may include:

  • Appetite control

  • Reduced food cravings

  • Weight management support

  • Improved metabolic balance

  • Support for healthy blood sugar regulation

Potential Side Effects may include:

  • Nausea (most common, especially early)

  • Decreased appetite

  • Constipation or diarrhea

  • Fatigue


Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist developed to support advanced metabolic and weight management goals. By targeting multiple metabolic pathways, tirzepatide may provide enhanced support for appetite control, insulin sensitivity, and body composition management

Potential benefits may include:

  • Enhanced appetite suppression

  • Metabolic optimization

  • Weight management support

  • Improved insulin sensitivity

  • Support for long-term wellness goals

Potential Side Effects may include:

  • Nausea (most common, especially early)

  • Decreased appetite

  • Constipation or diarrhea

  • Fatigue


Areas of ongoing clinical interest include:

  • Advanced metabolic support

  • Appetite regulation

  • Energy expenditure

  • Weight management

  • Cardiometabolic wellness

Retatrutide is an investigational next-generation peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. Current research is evaluating its potential role in metabolic health, energy balance, and weight management support.

Retatrutide

Potential Side Effects may include:

  • Nausea (most common, especially early)

  • Decreased appetite

  • Vomiting

  • Fatigue

Note: These products alone are not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not GLP-1 medications could be appropriate for you.

Frequently Asked Questions

Still have questions? Take a look at the FAQ or reach out anytime. If you’re feeling ready, go ahead and apply.